ÂÜÀòÂÒÂ×

David Kent is a Partnerships Manager at Sartorius Stedim Biotech since May 2023 and previously held roles in various organizations, including Senior Research Associate in Process Development at Fate Therapeutics Inc. from February 2022 to March 2023, and Cell Therapy Manufacturing Associate IV at NKGen Biotech, Inc. from March 2021 to February 2022. Kent's experience includes internships and consulting roles related to bioprocessing and cell therapy, as well as instruction in figure skating. Kent holds a Master of Engineering in Biopharmaceutical Processing from Keck Graduate Institute and a Bachelor of Science in Biotechnology with a minor in Chemistry from California State Polytechnic University-Pomona. Currently a PhD candidate in Applied Sciences at Keck Graduate Institute, Kent has a strong foundation in bioprocessing, cell culture techniques, and project management, complemented by a background in mentorship and team collaboration.